Brian G Feagan (B Feagan, Brian Feagan, B G Feagan)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 51

Top Topics

Systematic Review

Magnetic Resonance Imaging

Ulcerative Colitis

Endoscopic Submucosal Dissection

Top Venues

Alimentary pharmacology & therapeutics

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Florian Rieders, Mark E Baker, David Henry Bruining, Jeff L Fidler, Eric C Ehman, Shannon P Sheedy, Jay P Heiken, Justin M Ream, David R Holmes, Akitoshi Inoue, Payam Mohammadinejad, Yong S Lee, Stuart A Taylor, Jaap Stoker, Guangyong Zou, Zhongya Wang, Julie Rémillard, Rickey E Carter, Ronald Ottichilo, Norma Atkinson, Mohamed Tausif R Siddiqui, Venkata C Sunkesula, Christopher Ma, Claire E Parker, Julian Panes, Jordi Rimola, Vipul Jairath, Brian G Feagan, Joel G Fletcher, null null
Reliability of MR Enterography Features for Describing Fibrostenosing Crohn Disease. Radiology 312 (2) (2024)
Florian Rieders, Mark E Baker, David Henry Bruining, Jeff L Fidler, Eric C Ehman, Shannon P Sheedy, Jay P Heiken, Justin M Ream, David R Holmes, Akitoshi Inoue, Payam Mohammadinejad, Yong S Lee, Stuart A Taylor, Jaap Stoker, Guangyong Zou, Zhongya Wang, Julie Rémillard, Rickey E Carter, Ronald Ottichilo, Norma Atkinson, Mohamed Tausif R Siddiqui, Venkata C Sunkesula, Christopher Ma, Claire E Parker, Julian Panes, Jordi Rimola, Vipul Jairath, Brian G Feagan, Joel G Fletcher, null null
Reliability of MR Enterography Features for Describing Fibrostenosing Crohn Disease. Radiology 312 (2) (2024)
Florian Rieders, Christopher Ma, Jurij Hanžel, Joel G Fletcher, Mark E Baker, Zhongya Wang, Leonardo Guizzetti, Lisa M Shackelton, Julie Rémillard, Mihir Patel, Jiafei Niu, Ronald Ottichilo, Cynthia S Santillan, Nunzia Capozzi, Stuart A Taylor, David Henry Bruining, Guangyong Zou, Brian G Feagan, Vipul Jairath, Jordi Rimola, null null
Reliability of CT Enterography for Describing Fibrostenosing Crohn Disease. Radiology 312 (2) (2024)
Jie Shao, Marion Vetter, An Vermeulen, Brian G Feagan, Bruce E Sands, Julian Panes, Zhenhua Xu
Combination Therapy With Guselkumab and Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Pharmacokinetics, Immunogenicity and Drug-Drug Interactions. Clinical pharmacology and therapeutics (2024)
Florian Rieders, Christopher Ma, Jurij Hanžel, Joel G Fletcher, Mark E Baker, Zhongya Wang, Leonardo Guizzetti, Lisa M Shackelton, Julie Rémillard, Mihir Patel, Jiafei Niu, Ronald Ottichilo, Cynthia S Santillan, Nunzia Capozzi, Stuart A Taylor, David Henry Bruining, Guangyong Zou, Brian G Feagan, Vipul Jairath, Jordi Rimola, null null
Reliability of CT Enterography for Describing Fibrostenosing Crohn Disease. Radiology 312 (2) (2024)
Reena Khanna, Brian G Feagan, Guangyong Zou, Larry W Stitt, John W D McDonald, Brian Bressler, Remo Panaccione, Lisa M Shackelton, Tanja VanViegen, Edward V Loftus, Marco Daperno, Vipul Jairath, Geert R A M D'Haens, William J Sandborn
Reliability and Responsiveness of Clinical and Endoscopic Outcome Measures in Crohn's Disease. Inflammatory bowel diseases (2024)
Jie Shao, Marion Vetter, An Vermeulen, Brian G Feagan, Bruce E Sands, Julian Panes, Zhenhua Xu
Combination Therapy With Guselkumab and Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Pharmacokinetics, Immunogenicity and Drug-Drug Interactions. Clinical pharmacology and therapeutics 115 (6) (2024)
Florian Rieders, Mark E Baker, David Henry Bruining, Jeff L Fidler, Eric C Ehman, Shannon P Sheedy, Jay P Heiken, Justin M Ream, David R Holmes, Akitoshi Inoue, Payam Mohammadinejad, Yong S Lee, Stuart A Taylor, Jaap Stoker, Guangyong Zou, Zhongya Wang, Julie Rémillard, Rickey E Carter, Ronald Ottichilo, Norma Atkinson, Mohamed Tausif R Siddiqui, Venkata C Sunkesula, Christopher Ma, Claire E Parker, Julian Panes, Jordi Rimola, Vipul Jairath, Brian G Feagan, Joel G Fletcher, null null
Reliability of MR Enterography Features for Describing Fibrostenosing Crohn Disease. Radiology 312 (2) (2024)
Florian Rieders, Christopher Ma, Jurij Hanžel, Joel G Fletcher, Mark E Baker, Zhongya Wang, Leonardo Guizzetti, Lisa M Shackelton, Julie Rémillard, Mihir Patel, Jiafei Niu, Ronald Ottichilo, Cynthia S Santillan, Nunzia Capozzi, Stuart A Taylor, David Henry Bruining, Guangyong Zou, Brian G Feagan, Vipul Jairath, Jordi Rimola, null null
Reliability of CT Enterography for Describing Fibrostenosing Crohn Disease. Radiology 312 (2) (2024)
Jie Shao, Marion Vetter, An Vermeulen, Brian G Feagan, Bruce E Sands, Julian Panes, Zhenhua Xu
Combination Therapy With Guselkumab and Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Pharmacokinetics, Immunogenicity and Drug-Drug Interactions. Clinical pharmacology and therapeutics 115 (6) (2024)
Sudheer Kumar Vuyyuru, Lisa M Shackelton, Jurij Hanžel, Christopher Ma, Vipul Jairath, Brian G Feagan
Targeting IL-23 for IBD: Rationale and Progress to Date. Drugs (2023)
Niels Vande Casteele, William J Sandborn, Brian G Feagan, Séverine Vermeire, Parambir S Dulai, Andres Yarur, Xavier Roblin, Shomron Ben-Horin, Iris Dotan, Mark T Osterman, Maria Rosario, Teresa McRorie Osborn, Julian Panes, Dirk Lindner, Christian Agboton
Real-world multicentre observational study including population pharmacokinetic modelling to evaluate the exposure-response relationship of vedolizumab in inflammatory bowel disease: ERELATE Study. Alimentary pharmacology & therapeutics 56 (3) (2022)
Brian G Feagan, Reena Khanna, William J Sandborn, Séverine Vermeire, Walter Reinisch, Chinyu Su, Leonardo Salese, Haiyun Fan, Jerome Paulissen, Deborah A Woodworth, Wojciech Niezychowski, Bruce E Sands
Agreement between local and central reading of endoscopic disease activity in ulcerative colitis: results from the tofacitinib OCTAVE trials. Alimentary pharmacology & therapeutics 54 (11-12) (2021)
Rocio Sedano, Christopher Ma, Rish K Pai, Geert D' Haens, Leonardo Guizzetti, Lisa M Shackelton, Julie Remillard, Paolo Gionchetti, Ilyssa O Gordon, Stefan Holubar, Maia Kayal, Gregory Y Lauwers, Reetesh K Pai, Darrell S Pardi, Mark A Samaan, David F Schaeffer, Bo Shen, Mark S Silverberg, Brian G Feagan, William J Sandborn, Vipul Jairath
An expert consensus to standardise clinical, endoscopic and histologic items and inclusion and outcome criteria for evaluation of pouchitis disease activity in clinical trials. Alimentary pharmacology & therapeutics 53 (10) (2021)
Ilyssa O Gordon, Dominik Bettenworth, Arne Bokemeyer, Amitabh Srivastava, Christophe Rosty, Gert de Hertogh, Marie E Robert, Mark A Valasek, Ren Mao, Jiannan Li, Noam Harpaz, Paula Borralho, Reetesh K Pai, Robert Odze, Roger Feakins, Claire E Parker, Leonardo Guizzetti, Tran Nguyen, Lisa M Shackelton, William J Sandborn, Vipul Jairath, Mark Baker, David Bruining, Joel G Fletcher, Brian G Feagan, Rish K Pai, Florian Rieders, null null
International consensus to standardise histopathological scoring for small bowel strictures in Crohn's disease. Gut (2021)
Sushrut Jangi, Hyuk Yoon, Parambir S Dulai, Mark Valasek, Brigid Boland, Vipul Jairath, Brian G Feagan, William J Sandborn, Siddharth Singh
Letter: the combination of histologic remission and Mayo endoscopic score 1 as a suitable therapeutic target in ulcerative colitis-authors' reply. Alimentary pharmacology & therapeutics 53 (8) (2021)
Ahmed Almradi, Christopher Ma, Geert R D'Haens, William J Sandborn, Claire E Parker, Leonardo Guizzetti, Paula Borralho Nunes, Gert De Hertogh, Roger M Feakins, Reena Khanna, Gregory Y Lauwers, Aart Mookhoek, Reetesh K Pai, Laurent Peyrin Biroulet, Robert Riddell, Christophe Rosty, David F Schaeffer, Mark A Valasek, Siddharth Singh, Eileen Crowley, Brian G Feagan, Vipul Jairath, Rish K Pai
An expert consensus to standardise the assessment of histological disease activity in Crohn's disease clinical trials. Alimentary pharmacology & therapeutics 53 (7) (2021)
Jurij Hanžel, Christopher Ma, Niels Vande Casteele, Reena Khanna, Vipul Jairath, Brian G Feagan
Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease. Drugs 81 (3) (2021)
Thomas M Goodsall, Vipul Jairath, Brian G Feagan, Claire E Parker, Tran M Nguyen, Leonardo Guizzetti, Anil K Asthana, Jakob Begun, Britt Christensen, Antony B Friedman, Torsten Kucharzik, Andrew Lee, Peter J Lewindon, Christian Maaser, Kerri L Novak, Jordi Rimola, Kirstin M Taylor, Stuart A Taylor, Lauren S White, Rune Wilkens, Stephanie R Wilson, Emily K Wright, Robert V Bryant, Christopher Ma
Standardisation of intestinal ultrasound scoring in clinical trials for luminal Crohn's disease. Alimentary pharmacology & therapeutics 53 (8) (2021)
Sushrut Jangi, Hyuk Yoon, Parambir S Dulai, Mark Valasek, Brigid S Boland, Vipul Jairath, Brian G Feagan, William J Sandborn, Siddharth Singh
Predictors and outcomes of histological remission in ulcerative colitis treated to endoscopic healing. Alimentary pharmacology & therapeutics 52 (6) (2020)
Rish K Pai, Brian G Feagan, Claire E Parker, Vipul Jairath, Stephen Caldwell
Editorial: evolving histological assessment of NASH. Authors' reply. Alimentary pharmacology & therapeutics 50 (11-12) (2020)
Brian G Feagan, Mona Marabani, Jashin J Wu, Freddy Faccin, Claire Spronk, Gilberto Castañeda-Hernández
The Challenges of Switching Therapies in an Evolving Multiple Biosimilars Landscape: A Narrative Review of Current Evidence. Advances in therapy 37 (11) (2020)
Cathy Lu, Brandon Baraty, Helen Lee Robertson, Alexis Filyk, Hua Shen, Tak Fung, Kerri L Novak, Christopher Ma, Remo Panaccione, Jean-Paul Achkar, Sara El Ouali, David Bruining, Vipul Jairath, Brian G Feagan, Florian Rieders, null null
Systematic review: medical therapy for fibrostenosing Crohn's disease. Alimentary pharmacology & therapeutics 51 (12) (2020)
Edward V Loftus, Brian G Feagan, Remo Panaccione, Jean Frederic Colombel, William J Sandborn, Bruce E Sands, Silvio Danese, Geert R A M D'Haens, David T Rubin, Ira Shafran, Andrejus Parfionovas, Raquel Rogers, Richard A Lirio, Severine Vermeire
Long-term safety of vedolizumab for inflammatory bowel disease. Alimentary pharmacology & therapeutics 52 (8) (2020)
Parambir S Dulai, Vipul Jairath, Reena Khanna, Christopher Ma, Kelly P McCarrier, Mona L Martin, Claire E Parker, Joan Morris, Brian G Feagan, William J Sandborn
Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis. Alimentary pharmacology & therapeutics 51 (11) (2020)
Rish K Pai, Vipul Jairath, Brian G Feagan
Editorial: histologic normalisation in ulcerative colitis. Alimentary pharmacology & therapeutics 51 (3) (2020)
Robert Battat, Niels Vande Casteele, Rish K Pai, Zhongya Wang, Guangyong Zou, John W D McDonald, Marjolijn Duijvestein, Jenny Jeyarajah, Claire E Parker, Tanja Van Viegen, Sigrid A Nelson, Brigid S Boland, Siddharth Singh, Parambir S Dulai, Mark A Valasek, Brian G Feagan, Vipul Jairath, William J Sandborn
Evaluating the optimum number of biopsies to assess histological inflammation in ulcerative colitis: a retrospective cohort study. Alimentary pharmacology & therapeutics 52 (10) (2020)
Vipul Jairath, C Ma, Brian G Feagan
Editorial: aminosalicylates in Crohn's disease-prevalence, risks, costs and time to reassess? Authors' reply. Alimentary pharmacology & therapeutics 48 (4) (2019)
Adam Rahman, Vipul Jairath, Brian G Feagan, Reena Khanna, Salimah Z Shariff, Britney N Allen, Krista Bray Jenkyn, Christopher Vinden, Jenny Jeyarajah, Mahmoud Mosli, Eric Benchimol
Declining hospitalisation and surgical intervention rates in patients with Crohn's disease: a population-based cohort. Alimentary pharmacology & therapeutics 50 (10) (2019)
Parambir S Dulai, Aurelien Amiot, Laurent Peyrin Biroulet, Vipul Jairath, Melanie Serrero, Jerome Filippi, Siddharth Singh, Benjamin Pariente, Edward V Loftus, Xavier Roblin, Sunanda Kane, Anthony Buisson, Corey A Siegel, Yoram Bouhnik, William J Sandborn, Karen Lasch, Maria Rosario, Brian G Feagan, Daniela Bojic, Caroline Trang-Poisson, Bo Shen, Romain Altwegg, Bruce E Sands, Jean Frederic Colombel, Franck Carbonnel, null null
A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease. Alimentary pharmacology & therapeutics 51 (5) (2019)
Christopher Ma, Jeffrey K Lee, Anish R Mitra, Anouar Teriaky, Daksh Choudhary, Tran M Nguyen, Niels Vande Casteele, Reena Khanna, Remo Panaccione, Brian G Feagan, Vipul Jairath
Systematic review with meta-analysis: efficacy and safety of oral Janus kinase inhibitors for inflammatory bowel disease. Alimentary pharmacology & therapeutics 50 (1) (2019)
Siddharth Singh, Larry W Stitt, Guangyong Zou, Reena Khanna, Parambir S Dulai, William J Sandborn, Brian G Feagan, Vipul Jairath
Early combined immunosuppression may be effective and safe in older patients with Crohn's disease: post hoc analysis of REACT. Alimentary pharmacology & therapeutics 49 (9) (2019)
R K Pai, A J Bredenoord, Brian G Feagan, Vipul Jairath
Editorial: validating reliability of the eosinophilic oesophagitis histological scoring system (EOE-HSS)-an important first step. Authors' reply. Alimentary pharmacology & therapeutics 47 (12) (2019)
Gregor Novak, Toer W Stevens, Tanja Van Viegen, Peter Bossuyt, Borut Štabuc, Jenny Jeyarajah, Guangyong Zou, Ingrid C Gaemers, Trevor D McKee, Fred Fu, Lisa M Shackelton, Reena Khanna, Gijs R van den Brink, William J Sandborn, Brian G Feagan, Rish K Pai, Vipul Jairath, Niels Vande Casteele, Geert D'Haens
Evaluation of optimal biopsy location for assessment of histological activity, transcriptomic and immunohistochemical analyses in patients with active Crohn's disease. Alimentary pharmacology & therapeutics 49 (11) (2019)
Parambir S Dulai, Siddharth Singh, Vipul Jairath, Christopher Ma, Neeraj Narula, Niels Vande Casteele, Laurent Peyrin Biroulet, Severine Vermeire, Geert D'Haens, Brian G Feagan, William J Sandborn
Prevalence of endoscopic improvement and remission according to patient-reported outcomes in ulcerative colitis. Alimentary pharmacology & therapeutics 51 (4) (2019)
Florian Rieders, Brian G Feagan, Vipul Jairath, null null
Editorial: treating strictures in inflammatory bowel disease-authors' reply. Alimentary pharmacology & therapeutics 48 (11-12) (2019)
Christopher Ma, Robert Battat, Parambir S Dulai, Claire E Parker, William J Sandborn, Brian G Feagan, Vipul Jairath
Innovations in Oral Therapies for Inflammatory Bowel Disease. Drugs 79 (12) (2019)
Rish K Pai, David E Kleiner, John Hart, Oyedele A Adeyi, Andrew D Clouston, Cynthia A Behling, Dhanpat Jain, Sanjay Kakar, Mayur Brahmania, Lawrence Burgart, Kenneth P Batts, Mark A Valasek, Michael S Torbenson, Maha Guindi, Hanlin L Wang, Veeral Ajmera, Leon A Adams, Claire E Parker, Brian G Feagan, Stephen Caldwell, Vipul Jairath
Standardising the interpretation of liver biopsies in non-alcoholic fatty liver disease clinical trials. Alimentary pharmacology & therapeutics 50 (10) (2019)
M J Warners, C A Ambarus, A J Bredenoord, J Verheij, G Y Lauwers, J C Walsh, David A Katzka, S Nelson, T van Viegen, G T Furuta, S K Gupta, L Stitt, G Zou, C E Parker, Lisa M Shackelton, G R D Haens, W J Sandborn, E S Dellon, Brian G Feagan, M H Collins, Vipul Jairath, Rish K Pai
Reliability of histologic assessment in patients with eosinophilic oesophagitis. Alimentary pharmacology & therapeutics 47 (7) (2018)
Florian Rieders, D Bettenworth, C Ma, C E Parker, L A Williamson, S A Nelson, G van Assche, Antonio Di Sabatino, Y Bouhnik, Ryan William Stidham, Axel U Dignass, G Rogler, S A Taylor, J Stoker, J Rimola, M E Baker, J G Fletcher, J Panes, William J Sandborn, Brian G Feagan, V Jairath
An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn's disease. Alimentary pharmacology & therapeutics 48 (3) (2018)
Brian G Feagan, Gordon Lam, Christopher Ma, Gary R Lichtenstein
Systematic review: efficacy and safety of switching patients between reference and biosimilar infliximab. Alimentary pharmacology & therapeutics 49 (1) (2018)
William J Sandborn, P Rutgeerts, C Gasink, D Jacobstein, B Zou, J Johanns, B E Sands, Stephen Hanauer, S Targan, Subrata Ghosh, W J S de Villiers, Jean Frederic Colombel, Brian G Feagan
Long-term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapy. Alimentary pharmacology & therapeutics 48 (1) (2018)
Christopher Ma, S J Dutton, L E Cipriano, Siddharth Singh, C E Parker, T M Nguyen, L Guizzetti, J C Gregor, N Chande, P Hindryckx, Brian G Feagan, Vipul Jairath
Systematic review with meta-analysis: prevalence, risk factors and costs of aminosalicylate use in Crohn's disease. Alimentary pharmacology & therapeutics 48 (2) (2018)
Christopher Ma, Leonardo Guizzetti, R Panaccione, Richard N Fedorak, Rish K Pai, C E Parker, T M Nguyen, R Khanna, Niels Vande Casteele, Geert R A M D'Haens, William J Sandborn, Brian G Feagan, Vipul Jairath
Systematic review with meta-analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitis. Alimentary pharmacology & therapeutics 47 (12) (2018)
Christopher Ma, Vipul Jairath, Reena Khanna, Brian G Feagan
Investigational drugs in phase I and phase II clinical trials targeting interleukin 23 (IL23) for the treatment of Crohn's disease. Expert opinion on investigational drugs 27 (8) (2018)
Christopher Ma, Leonardo Guizzetti, Lauren E Cipriano, Claire E Parker, Tran M Nguyen, James C Gregor, Nilesh Chande, Brian G Feagan, Vipul Jairath
Systematic review with meta-analysis: high prevalence and cost of continued aminosalicylate use in patients with ulcerative colitis escalated to immunosuppressive and biological therapies. Alimentary pharmacology & therapeutics 49 (4) (2018)
M A Samaan, C A J Puylaert, B G Levesque, G Y Zou, L Stitt, S A Taylor, Lisa M Shackelton, M K Vandervoort, R Khanna, C Santillan, J Rimola, P Hindryckx, C Y Nio, W J Sandborn, G D'Haens, Brian G Feagan, Vipul Jairath, J Stoker
The development of a magnetic resonance imaging index for fistulising Crohn's disease. Alimentary pharmacology & therapeutics 46 (5) (2017)
P B Allen, P Olivera, P Emery, D Moulin, J-Y Jouzeau, P Netter, S Danese, Brian G Feagan, W J Sandborn, L Peyrin-Biroulet
Review article: moving towards common therapeutic goals in Crohn's disease and rheumatoid arthritis. Alimentary pharmacology & therapeutics 45 (8) (2017)
G R D'Haens, W J Sandborn, G Zou, L W Stitt, P J Rutgeerts, D Gilgen, V Jairath, P Hindryckx, Lisa M Shackelton, M K Vandervoort, C E Parker, C Muller, R K Pai, O Levchenko, Y Marakhouski, M Horynski, E Mikhailova, N Kharchenko, S Pimanov, Brian G Feagan
Randomised non-inferiority trial: 1600 mg versus 400 mg tablets of mesalazine for the treatment of mild-to-moderate ulcerative colitis. Alimentary pharmacology & therapeutics 46 (3) (2017)
Vipul Jairath, Brian G Feagan
Editorial: the impact of the placebo effect in Crohn's disease - author's reply. Alimentary pharmacology & therapeutics 45 (11) (2017)
V Jairath, G Zou, C E Parker, J K MacDonald, M H Mosli, T AlAmeel, M Al Beshir, M AlMadi, T Al-Taweel, N S S Atkinson, S Biswas, T P Chapman, P S Dulai, M A Glaire, D Hoekman, O Kherad, A Koutsoumpas, E Minas, S Restellini, M A Samaan, R Khanna, B G Levesque, G D'Haens, W J Sandborn, Brian G Feagan
Systematic review with meta-analysis: placebo rates in induction and maintenance trials of Crohn's disease. Alimentary pharmacology & therapeutics 45 (8) (2017)